Watch Ticker

Aurinia Pharmaceuticals Inc

Go to Aurinia Pharmaceuticals Inc Website

$11.73

0.28 (2.45%)

Live

Previous Close

$11.45

Day Range

$11.2703 - $11.76

Previous Day Range

$10.4501 - $11.48

Market Cap

$1.4 billion USD

Day Vol.

2.2 million

Previous Day Vol.

5.1 million

Currency

USD

Primary Exchange

Nasdaq

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Spherix Global Insights - New American College of Rheumatology Guidelines for Lupus Nephritis Recommend Triple Therapy, Highlighting a Shift in Current Treatment Practices, According to Spherix Global Insights

The American College of Rheumatology has updated its guidelines for treating lupus nephritis, recommending early use of triple therapy (mycophenolate mofetil, glucocorticoids, and either Benlysta or a calcineurin inhibitor). However, current practice often delays initiating triple therapy until initial treatment failure.

Related tickers: GSK, AUPH.

Read Full Article

American Kidney Fund - Corporate and Individual Donations Provide Much-Needed Support to Kidney Patients Impacted by Hurricane Helene Through the American Kidney Fund’s Disaster Relief Program

The American Kidney Fund's Disaster Relief Program is providing emergency financial assistance to dialysis and recent transplant patients in areas affected by Hurricane Helene. The program has received generous support from various companies and individual donors to help cover expenses related to lost medications, housing, transportation, and personal essentials.

Related tickers: AUPH, ARDX.

Read Full Article

Trending Tickers

Please sign in to view